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Edited by Stuart FergusonAbstract In this work, we have spectroscopically characterised
CYP157C1 from Streptomyces coelicolor A3(2) which has the
motif E297QSLW301 rather than the invariant EXXR motif in
the P450 K-helix. Site-directed mutagenesis of native
E297QSLW301 in CYP157C1 to E297ESLR301 or E297QSRW301
both containing standard EXXR motifs produced cytochrome
P420 proteins thought to be inactive forms of P450 even though
wild type CYP157C1 has the spectral properties of a normal
P450. These results indicate that the EXXR motif is not required
in all CYP tertiary architectures and only a single cysteine resi-
due, which coordinates as the ﬁfth thiolate ligand to the P450
haem iron, is invariant in all CYPs structures.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cytochromes P450 (CYP) represent a superfamily of haem-
containing enzymes that catalyse the monooxygenation of a
wide array of structurally diverse substrates [1,2]. Genome
sequencing projects have revealed the enormous biodiversity
of the superfamily with >6500 CYPs being identiﬁed in bacte-
ria, fungi, insects, worms, plants, ﬁsh and mammals (http://
drnelson.utmem.edu/CytochromeP450.html; http://p450.anti-
bes.inra.fr; http://Arabidopsis-P450.biotec.uiuc.edu). Catalyti-
cally, upon substrate binding, CYPs are initially reduced by
a single electron transfer from an ancillary protein(s), which
is generally, ferredoxin (fd) and ferredoxin reductase (fpr) for
prokaryotic CYPs, NADPH cytochrome P450 reductase
(CPR) for eukaryotic microsomal CYPs and adrenodoxin
and adrenodoxin reductase for eukaryotic mitochondrial
CYPs, followed by oxygen binding and further reduction by
a second electron that then allows CYP-catalysed molecularAbbreviations: CYP, cytochrome P450; PCR, polymerase chain reac-
tion
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doi:10.1016/j.febslet.2006.10.043scission of oxygen to proceed. Finally, one atom of oxygen is
inserted into the substrate while the second atom is reduced
to water via two protons from the bulk solvent interface (for
reviews see [3–5]).
Previously, continued analysis of all CYP amino acid se-
quences deposited in a variety of databases revealed only three
residues which were thought to be absolutely conserved in
CYP proteins. The ﬁrst residue is an invariant cysteine which
constitutes the ﬁfth ligand to the haem within the Cys pocket
adjacent to the L-helix [6]. This cysteine residue is part of a
stretch of nine amino acids forming a b bulge region in which
three residues, two glycines and one phenylalanine are gener-
ally, but not absolutely, conserved. The second and third
invariant residues in most P450s are glutamic acid and arginine
within the conserved EXXR motif found in the K-helix [7].
Both of these residues and either a histidine, arginine or aspar-
agine from the meander region form a set of salt–bridge inter-
actions that participate in the formation of the ﬁnal CYP
tertiary structure with increasing evidence suggesting that
EXXR is linked somehow to haem association with the CYP
polypeptide ([8], Fig. 1). In support of this notion, site-directed
mutagenesis of the invariant cysteine, glutamic acid or arginine
in individual CYPs resulted in the formation of completely
inactive and misfolded P450 isoforms [9,10].
Here, we report a novel CYP subfamily from Streptomyces
sp. (CYP157C) [11] in which most members lack the EXXR
motif previously thought to be invariant. We show that
CYP157C1, which contains Q298XXW301 instead of EXXR
(Fig. 2), is indeed a cytochrome P450 and that site-directed
mutagenesis of this K-helix region to a variety of other amino
acids including the EXXR motif results in improperly folded
P420 protein. Our results demonstrate that the EXXR region
is not as essential to CYP architecture as previously thought
and that the only invariant residue in all CYP proteins should
now be considered to be the cysteine that is the ﬁfth ligand
with the haem iron.2. Materials and methods
2.1. General methods
Reduced carbon monoxide diﬀerence spectra for quantiﬁcation of
cytochrome P450 content were measured and calculated according to
the method described by Omura and Sato [12]. Protein quantiﬁcationsblished by Elsevier B.V. All rights reserved.
Fig. 1. View of the essentially invariant EXXR motif in the crystal
structure of CYP158A2. Glutamic acid and arginine residues (shown
with grey/blue and grey/red side chains, respectively), part of the
EXXR motif in the K-helix (shown with a purple backbone) and either
a histidine, arginine or asparagine from the meander region (shown
with a gold backbone) form a set of salt–bridge interactions that are
proposed to participate in the formation of the ﬁnal CYP tertiary
structure in order to facilitate haem incorporation (shown in red).
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albumin as a standard. Unless otherwise stated, all chemicals where
supplied by Sigma Chemical Company (Poole, Dorset, UK).
2.2. Expression and mutagenesis
The CYP157C1 protein was genetically engineered to contain a
His4-tag at its carboxy-terminus using a polymer chain reaction
(PCR)-based strategy as described previously [11]. The resulting
CYP157C1WT-His4 sequence was then cloned into pET17b (yielding
CYP157C1WT:pET17b) and transformed into Escherichia coli
strain BL21(pLys)DE3 for expression analysis. The QuikChange
mutagenesis kit (Stratagene) was used for the construction of
site-directed mutants employing PCR. The primers used for the
introduction of mutations were as follows: L300R forward:
5 0-ATGACGGTGCCCCAGGCGGTCGAGCAGTCCCGTTGGGA-
CGAGCCG-3 0; L300R reverse: 5 0-CGGCTCGTCCCAACGGGA-
CTGCTCGACCGCCTGGGGCACCGTCAT-3 0; Q298E forward:
5 0-CAGGCGGTCGAGGAGTCCCTGTGGGAC-3 0; Q298E reverse:
5 0-GTCCCACAGGGACTCCTCGACCGCCTG-3 0; W301R forward
5 0-CGGCGGCTCGTCCCGCAGGGACTGCTC-3 0; W301R reverse
5 0-GAGCAGTCCCTGCGGGACGAGCCGCCG-3 0. The integrity
of the CYP157C1 wildtype and mutant sequences were conﬁrmed
by DNA sequencing.CYP157A1        AASLFGGRNSVAEAMNEVLWEDTPTQN
CYP157B1        ALNVSGGRLSVGEALNEVLWLDTPTQN
CYP157C1        RAQLSGGQMTVPQAVEQSLWDEPPFST
CYP157C2        RAQLNGGQMTVPEAVEQSLWDEPPFST
CYP157C3        RARLSGGHMTVPEAVEQTLWDEPPFTA
CYP157C4        RANLAGGHMTLPDALEQVLWDEPPLSV
CYP154C1        RALVLSGEAEWSAVVEETLRFSTPTSH
CYP158A2        AERLRSEPEIRPRAIDELLRWIPHRNA
                   : .       .::: *   .    
K
Fig. 2. K-helix alignment of ﬁve members of the CYP157 family with CYP154
of S. coelicolor A3(2) CYP157A1, CYP157B1 and CYP157C1, S. avermitili
CYP154C1 is shown with the variant EXXR motif in the CYP157 subfami
CYP154C1 shown in red.2.3. Characterisation of expressed proteins
Single ampicillin/kanamycin-resistant colonies from each transform-
ant were grown overnight at 37 C in 5 ml of Terriﬁc Broth consisting
of 1.2% (w/v) Bactotryptone (Difco), 2.4% (w/v) yeast extract (Difco),
0.4% (v/v) glycerol supplemented with 100 lg/ml ampicillin and 50 lg/
ml kanamycin. These pre-cultures were inoculated into 500 ml of mod-
iﬁed Terriﬁc Broth media also containing 100 lg/ml ampicillin and
50 lg/ml kanamycin (1:100 culture dilution). After 4 h growth at
37 C in a shaking incubator at 240 rpm, the culture was induced to ex-
press CYP by the addition of isopropyl b-D-thiogalactopyranoside
(IPTG) to a ﬁnal concentration of 1 mM and d-aminolevulinic acid
to a ﬁnal concentration of 1 mM (to ensure optimal CYP expression)
and induced to express chaperones by addition of arabinose to a ﬁnal
concentration of 4 mg/ml. Using three 500 ml cultures (1.5 l total),
growth was continued at 28 C with shaking at 190 rpm for 38 h and
the E. coli cells were pelleted by centrifugation at 1500 · g and resus-
pended in 100 ml potassium phosphate buﬀer (pH 7.4) containing
500 mM sodium acetate, 20% glycerol, 0.1 mM EDTA, 0.1 mM dithi-
othreitol, 0.1 mM PMSF, 1% sodium cholate and 1% Tween 20. Cells
were broken by freeze–thawing as previously described [11] and the
cytosolic fraction was separated from cell debris and the membrane
fraction by ultracentrifugation at 100000 · g for 45 min.
2.4. Molecular modelling of CYP157C1 and high throughput substrate
docking
A molecular model of CYP157C1 was generated after aligning 13
Class I and Class III P450s to create a ‘‘ﬁxed’’ alignment as described
in [13]. In this alignment, CYP157C1 shared the highest amino acid
identity with CYP154C1 (28.8%). Therefore, models were generated
using the crystal structure of CYP154C1 [14] as a single template
and MOE programs (Chemical Computing Group, Montreal).
CYP157C1 model has a normalized Z score of 0.90 (obtained from
ProsaII), and a normalized 3D-1D score of 0.98 (from Proﬁles 3D) well
above the cutoﬀ of 0.6.3. Results and discussion
As previous heterologous expression of CYP157C1 in E. coli
produced extremely low levels of protein (<10 nmol CYP/L
culture) preventing biochemical analysis of this protein [11],
we established an eﬃcient system for expression by coexpress-
ing it with the molecular chaperones GroES and GroEL that
have been shown to enhance the production of active and cor-
rectly folded human CYPs [15,16]. In this co-expression sys-
tem, GroES and GroEL coding regions are under the
control of the AraB promoter allowing them to be induced
by the addition of arabinose. In the presence of these proteins,
expression of active CYP157C1 was greatly enhanced with
levels of CYP reaching >250 nmol P450/L culture after 38 h
of culture. Subsequent fractionations indicated that the over-
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C1 and CYP158A2 from Streptomyces coelicolor A3(2). The alignment
s CYP157A2 and CYP157C2 and S. coelicolor A3(2) CYP158A2 and
ly shown in aqua and the consensus EXXR motif in CYP158A2 and
Fig. 3. Reduced carbon monoxide diﬀerence spectral analysis of wild type and mutant CYP157C1 proteins. Spectra were recorded from bacterial
cytosolic extracts as described in Section 2. (A) Native CYP157C1 shows classical P450 spectral oxidized (red), reduced (black), reduced-CO (blue),
(B) Reduced carbon monoxide diﬀerence spectra, wild type (aqua), Q298E mutant (purple), W301R mutant (black), Q298E/W301R double mutant
(red).
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diﬀerence analysis (Fig. 3).
Site-directed mutants of CYP157C1 with altered K-helix
regions were expressed using this chaperone co-expression
system. According to resolved crystal structures of many
prokaryotic and eukaryotic CYPs, the invariant EXXR motif
found in the K-helix of both classes of these P450s forms a net-
work of salt–bridge interactions that are proposed to facilitate
haem binding [8]. However, in CYP157C1 the EXXR region is
absent and replaced with the Q298SLW301 motif. Clearly, these
substitutions are not conservative with the negatively charged
glutamate being replaced with the uncharged polar amide
derivative glutamine and the positively charged arginine
replaced with the hydrophobic residue tryptophan.
To assess the importance of these residues in the tertiary
structure of CYP157C1, the native E297QSLW301 sequence
was changed to E297ESLR301 as well as to E297QSRW301 both
containing the more canonical EXXR sequence. While crea-
tion of the ﬁrst of these site-directed mutants necessitated
replacements at two positions within this heptapeptide, crea-
tion of the second of these site-directed mutants took advan-
tage of the proximal E297 to accommodate construction of
this motif. As shown in Fig. 3, reduced carbon monoxide spec-
tra revealed mostly incorrectly folded protein for the
E297ESLR301 double mutant and each of its single mutants;
the same results were also found for the E297QSRW301 single
mutant (data not shown) and for CYP157C1 mutants contain-
ing EXXR which are expressed in the absence of chaperones.
These results indicate that, in this CYP, EXXR is not required
for correct protein folding in direct contrast to the CYP super-
family as a whole. Further, our results reveal P420 production
is not through uncoupling of protein synthesis and haem incor-
poration. The introduction of the double mutant shows that
EXXR is not tolerated within the CYP157C1 tertiary structure
as this P450 has evolved to dispense of this motif. Expression
with chaperones would have helped P450 production as the re-
sults of the wild type reveal, but this was not the case for the
mutant expression analysis. The several previous studies indi-
cating that EXXR is critical for correct P450 folding include
mutagenesis of Arg365 in CYP19A1 which led to the produc-
tion of inactive and misfolded protein [17] and mutagenesis of
the corresponding Arg residue in CYP1A2 which led to inac-
tive protein that could not bind haem [10]. In other studies,Hatae and colleagues [9] mutated both Glu347 and Arg350
of CYP8A1 to Ala which again abolished enzyme activity
while mutation of Glu359 and Arg362 in bovine CYP17A1
also led to inactive protein (Barnes and Waterman, unpub-
lished data). In all cases, no correctly folded P450s were ob-
served.
To provide more insight into the reasons that CYP157C1
can correctly fold in the absence of the conserved EXXR, a
molecular model was built using our resolved crystal structure
of Streptomyces coelicolor CYP154C1 as a template [14]. Fig. 4
shows the CYP154C1 crystal structure (top panel) compared
with our derived CYP157C1 model (bottom panel) with the
E and R (CYP154C1) and Q and W (CYP157C1) residues
highlighted. In CYP154C1, the highly conserved EXXR motif
in the K-helix can form not only a salt–bridge interaction with-
in it, but also an extensive network of hydrogen bonds with
adjacent amino acid residues located in meander region. For
example, the guanidium group of R284 forms hydrogen bonds
with the carbonyl oxygen atoms of A332 and R334. The side
chain of E281 can make hydrogen bonds interaction with
D336 and R339 (Fig. 4, top). In our CYP157C1 model, these
hydrogen bonding contacts are disrupted owing to presence
of residues Q298 and W301. Although Q298 and W301 cannot
form hydrogen bonds with each other, the side chain of Q298
can still make hydrogen bonds with residues in the meander re-
gion and the adjacent D302 makes extensive hydrogen bonds
with the same region (Fig. 4, bottom), which may stabilise
the incorporation of haem. The predicted orientation of
Q298SLW301 in the CYP157C1 model does not aﬀect the helical
conformation of the K-helix. Since we have made mutations in
the K-helix creating an EXXR but have not made mutations in
the meander region, it is possible that the synthetic EXXR
motif in CYP157C1 cannot support normal P450 folding be-
cause the meander is not designed to match correct hydrogen
bonding. It is not obvious what mutations might be made in
the meander region to match a synthetic EXXR in CYP157C1,
but future studies should address this point. However, we can
conclude EXXR is not required for normal P450 folding in
CYP157C1. Perhaps other hydrogen bonds predicted in our
model stabilize haem binding (Fig. 4).
The biological role of CYP157C1 remains unknown but
clues to function can be gained from comparison of the
CYP157C1 genetic organization with other S. coelicolor genes
Fig. 4. Location of the EXXR and QXXW sequences in the
CYP154C1 crystal structure (top) and CYP157C1 model (bottom).
The presence of E and R in CYP154C1 (shown in red) can form salt–
bridge interaction with each other, and also they are able to form an
extensive network of hydrogen bonds with adjacent amino acid
residues located in meander region, which has been speculated to allow
stable incorporation of haem during correct CYP protein folding.
However, the hydrogen bond network in CYP157C1 in very diﬀerent
because of the presence of Q and W residues (shown in orange)
suggesting an as yet undetermined mechanism(s) for haem stabilization
in this CYP. The potential hydrogen bonds are shown in dotted lines.
The side chain atoms are rendered as stick ﬁgures (grey, carbon; blue,
nitrogen; red, oxygen).
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is the terminal gene of a ﬁve gene cluster termed ‘conservon’
[18]. In S. coelicolor A3(2), 13 such clusters were found (cvnA,
B, C, D, 1–13) with unidirectional transcription and overlaps
in translational start and stop codons suggesting that these ex-
ist as a single operon [18]. Each conservon contains a predicted
sensor kinase (cvnA), an ATP-binding protein (cvnD) as well as
two ORFs of unknown function (cvnB and cvnC). In four of
these S. coelicolor A3(2) conservons, the next downstream
ORF codes for a CYP and, in two of these conservons, two
downstream CYPs exist. In S. coelicolor A3(2) cvn10, the
downstream CYPs include CYP157A1 (which has no EXXRmotif) and CYP154C1 (which has the EXXR motif); in
cvn11, the downstream CYP is CYP157B1 (which has no
EXXR motif) [11]; in cvn12, the downstream CYPs are
CYP156A1 (which has no EXXR motif) and CYP154A1
(which has the EXXR motif); in cvn13, the downstream CYP
is CYP157C1 (which has no EXXR motif). Analysis of the
genome sequence of S. avermitilis has also identiﬁed 11 con-
servons with two of these followed by downstream ORFs cod-
ing for CYPs [19]. In cvnC9, the downstream CYPs are
CYP157A2 (which has no EXXR motif) and CYP154C2
(which has the EXXR motif) and, in cvnC10, the downstream
CYP is CYP157C2 (which has no EXXR motif). It is clear
from these organizations that the CYP157 family proteins
which lack consensus EXXR motifs are all genetically linked
to their upstream conservons suggesting that they have func-
tions linked to the encoded pathway(s). The involvement of
CYPs in the function of these conservons is a key target for
studies on the roles of CYP in streptomycetes and should lead
to the determination of the function of CYPs lacking the con-
served EXXR motif.
Second, studies in S. coelicolor A3(2) have indicated that
mutation of bldA (encoding the tRNA for the rare leucine
UUA codon) causes pleiotropic deﬁciencies in both the devel-
opment of aerial hyphae and the production of antibiotics [20].
The completed S. coelicolor A3(2) genome identiﬁed a total of
145 genes containing one or more TTA codons and each was
aﬀected by bldA mutations [18]. Given that bldA deletion itself
is not lethal to the organism then it can be assumed that muta-
tions of any of the 145 genes containing a TTA codon are also
not lethal. CYP157C1 is the only member of the P450 super-
family in S. coelicolor containing a rare TTA codon. Hence,
it can be speculated that CYP157C1 has a role in the produc-
tion of aerial hyphae or, more likely, a role in antibiotic pro-
duction via oxidative tailoring associated with bldA. Gene
deletion of CYP157C1 followed by comparison of secondary
metabolite compositions in wild type and mutant strains is cur-
rently being investigated as a means to deciphering the biolog-
ical function of CYP157C1.
Lastly, one other S. coelicolor A3(2) P450 (CYP156A1) does
not contain an EXXR motif [10] but, like other CYP157 family
members not containing EXXR, it is expected to be a
functional enzyme. It certainly will be interesting to solve the
high resolution X-ray structure of one of these CYPs to obtain
a detailed understanding of how the absence of EXXR
inﬂuences P450 structure. Even after completion of such struc-
tures, however, the evolutionary description of why certain
CYPs have eliminated EXXR from their sequence will remain
puzzling.
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